Skip to content

Study for prevention and treatment of normal blood pressure in Guangzhou urban community based on cloud platform and big data technology

Study for prevention and treatment of normal blood pressure in Guangzhou urban community based on cloud platform and big data technology

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800019527
Enrollment
Unknown
Registered
2018-11-16
Start date
2018-11-20
Completion date
Unknown
Last updated
2018-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prehypertension

Interventions

Case series:Nil

Sponsors

Guangdong General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Aged at least 18 years old; Blood pressure 120~139mmHg / 80 ~ 89 mmHg. The informed life and follow-up are expected. The life expectancy is more than 1 year.

Exclusion criteria

Exclusion criteria: Patients with essential hypertension or are taking antihypertensive drugs, secondary hypertension; acute myocardial death and acute stroke; accompanied by severe cardiomyopathy, rheumatic heart disease, congenital heart disease; severe liver and kidney disease; combined with malignant tumor, serious Autoimmune diseases, etc.; those with a history of allergies or clear contraindications to the study drug; a clear diagnosis of left ventricular hypertrophy, carotid thickening or plaque, hypertensive fundus changes, and no follow-up.

Design outcomes

Primary

MeasureTime frame
blood pressure;home blood pressure;Living habits and other questionnaires;Heart, brain and kidney disease and death;blood lipid;blood sugar;Liver and kidney function;Urine test;Carotid artery color Doppler;Electrocardiogram;Urinary albumin/creatinine ratio;

Secondary

MeasureTime frame
Sleep questionnaire;Simple mental scale;Hospitalized due to illness;Echocardiography;Pulse wave velocity;Inflammatory marker;Uric acid;Homocysteine;

Countries

China

Contacts

Public ContactFENG Yingqing

Guangdong General Hospital

fyq1819@163.cpm+86 13602863389

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026